Shaanxi adjusts the price limit of abiolone acetate and apixaban acetate
All medical institutions: according to the application of the enterprise, for abiolone acetate tablets (drug No.: 8184934, specification: 0.25g * 60 Tablets) and apixaban tablets (drug No.: 8185965, specification: 2.5mg) produced by Zhengda Tianqing Pharmaceutical Group Co., Ltd *The price limit of 14 tablets) was adjusted to 1436 yuan and 350 yuan respectively; the price limit of abitrone acetate tablets (drug No.: 8184933, specification: 0.25g * 120 tablets) produced by Chengdu Shengdi Pharmaceutical Co., Ltd. was adjusted to 3828 yuan. The adjusted price of the above-mentioned drugs shall be implemented from now on. Shaanxi public resources trading center February 18, 2020
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
Recommend Reading
-
Two Saudi Crude Supertankers Hit in Hormuz as Brent Surges to Nearly $95
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Bridgestone Reports Q3 Growth Amid Challenging North American Market
-
Toxic Ammonia Leak Prompts Emergency Response in Mississippi
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Paraffin Wax vs. Beeswax: Candles, Cosmetics, and Industrial Applications
-
Lanolin: Benefits for Skin, Cosmetic Uses, and Allergy Risks
-
Downstream Replenishment: EVA Market Prices Have Slightly Risen Recently
-
This Week, the Transaction Focus of China's Propylene Oxide Market Rises (11.10-11.14)